AVE 20.0% 0.2¢ avecho biotechnology limited

pre announce, page-35

  1. 215 Posts.
    "It's pretty clear though that the product is intended to "treat" mastitis as an alternative to antibiotics."

    This statement is not quite correct by my interpretation. I read that it is intended to treat sub-clinical mastitis as an alternative to antibiotics. Not active, clinical, mastitis. i.e. not therapeutic.

    There is a big difference between sub-clinical mastitis and clinical mastitis.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(20.0%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $2 1.126K

Buyers (Bids)

No. Vol. Price($)
22 34751789 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40153304 27
View Market Depth
Last trade - 12.40pm 08/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.